Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Antengene Biologics Limited

Clinical trials sponsored by Antengene Biologics Limited, explained in plain language.

Now part of Antengene Corporation Limited 6996 HKEX

Biopharmaceutical company developing innovative oncology and hematology drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet recruiting 1 Terminated 1

New drug ATG-031 targets Hard-to-Treat cancers in first human trial

Disease control Terminated

This study tests an experimental drug called ATG-031 in people with advanced solid tumors or B-cell non-Hodgkin lymphomas that have not responded to standard treatments. The main goals are to check the drug's safety and find the best dose. Participants receive ATG-031 by infusion…

Phase: PHASE1 • Sponsor: Antengene Biologics Limited • Aim: Disease control

Last updated Jul 18, 2026 00:00 UTC